Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Papillary Carcinoma of Thyroid Gland”

227 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 227 results

Not applicableNot Yet RecruitingNCT07218315
What this trial is testing

Nanosecond Pulsed Field Ablation in the Management of T1N0M0 Papillary Thyroid Carcinoma

Who this might be right for
Thyroid Carcinoma
M.D. Anderson Cancer Center 15
Not applicableUnknownNCT03377829
What this trial is testing

Trial of PLA vs. Surgery for Treating PTMC

Who this might be right for
Thyroid CancerTreatment Related Cancer
WeiWei Zhan 200
Post-approval studies (Phase 4)UnknownNCT05247476
What this trial is testing

Type 2 Deiodinase Gene Polymorphism and the Treatment of Hypothyroidism Caused by Thyroidectomy in Thyroid Cancer Patients.

Who this might be right for
Thyroid Cancer, PapillaryHypothyroidism
Zhongshan Hospital Xiamen University 50
Not applicableStudy completedNCT06235814
What this trial is testing

Molecular Analysis for Precision Surgery in Thyroid Cancer Trial

Who this might be right for
Papillary Thyroid Cancer
University of California, Los Angeles 2
Not applicableUnknownNCT00984191
What this trial is testing

Pilot 99mTechnetium-MIBI Single Photon Emission Computed Tomography - Computed Tomography (SPECT-CT) in Papillary Carcinoma (CA) Thyroid

Who this might be right for
Papillary Thyroid Cancer
Chulalongkorn University 15
Not applicableLooking for participantsNCT06133374
What this trial is testing

Concordance of Molecular Classification Based on Fine Needle Biopsy (FNB) and Surgical Samples

Who this might be right for
Papillary Thyroid Cancer
University of Calgary 130
Not applicableActive Not RecruitingNCT03271892
What this trial is testing

Deciding on Active Surveillance or Surgery for Primary Management of Low Risk Papillary Thyroid Cancer

Who this might be right for
Thyroid Cancer Stage I
University Health Network, Toronto 200
Not applicableLooking for participantsNCT06333587
What this trial is testing

Minimally Invasive Treatments of the Thyroid

Who this might be right for
Papillary Thyroid Microcarcinoma
European Institute of Oncology 270
Testing effectiveness (Phase 2)Active Not RecruitingNCT02650401
What this trial is testing

Study Of Entrectinib (Rxdx-101) in Children and Adolescents With Locally Advanced Or Metastatic Solid Or Primary CNS Tumors And/Or Who Have No Satisfactory Treatment Options

Who this might be right for
Solid TumorsCNS Tumors
Hoffmann-La Roche 69
Not applicableEnded earlyNCT05014698
What this trial is testing

IDEntification of New Predisposition Genes in Differentiated THYroid Cancer

Who this might be right for
Differentiated Thyroid CancerThyroid Cancer, Nonmedullary
Nantes University Hospital 34
Not applicableStudy completedNCT01927887
What this trial is testing

Pre-Operative Nodal Staging of Thyroid Cancer Using USPIO MRI: Preliminary Study

Who this might be right for
Papillary Carcinoma of Thyroid GlandMetastatic Medullary Thyroid CancerFollicular Thyroid Cancer Lymph Node Metastasis
Massachusetts General Hospital 12
Testing effectiveness (Phase 2)Study completedNCT00389441
What this trial is testing

Study Of AG-013736 In Patients With 131I-Refractory Thyroid Cancer

Who this might be right for
Thyroid Neoplasms
Pfizer 52
Testing effectiveness (Phase 2)UnknownNCT05675605
What this trial is testing

TY-1091 in Patients With Advanced Solid Tumors

Who this might be right for
RET-altered Non Small Cell Lung CancerMedullary Thyroid CancerRET-altered Papillary Thyroid Cancer+1 more
TYK Medicines, Inc 248
Not applicableStudy completedNCT05132205
What this trial is testing

Radiofrequency Ablation of Papillary Thyroid Microcarcinoma

Who this might be right for
Papillary Thyroid Cancer
Johns Hopkins University 10
Testing effectiveness (Phase 2)Study completedNCT00729157
What this trial is testing

Aflibercept in Treating Patients With Recurrent and/or Metastatic Thyroid Cancer That Did Not Respond to Radioactive Iodine Therapy

Who this might be right for
Recurrent Thyroid Gland CarcinomaStage III Thyroid Gland Follicular CarcinomaStage III Thyroid Gland Papillary Carcinoma+2 more
National Cancer Institute (NCI) 41
Not applicableActive Not RecruitingNCT04624477
What this trial is testing

Active Surveillance and Surgery Outcomes in Low Risk Papillary Thyroid Cancer

Who this might be right for
Papillary Thyroid CancerPapillary Thyroid CarcinomaPapillary Microcarcinoma of the Thyroid
University Health Network, Toronto 450
Not applicableApproved For MarketingNCT03906331
What this trial is testing

Expanded Access for the Treatment of Cancers With Rearranged During Transfection (RET) Activation

Who this might be right for
Non Small Cell Lung CancerMedullary Thyroid CancerColon Cancer+4 more
Eli Lilly and Company
Testing effectiveness (Phase 2)Ended earlyNCT03753919
What this trial is testing

Durvalumab Plus Tremelimumab for the Treatment of Patients with Progressive, Refractory Advanced Thyroid Carcinoma -The DUTHY Trial

Who this might be right for
Metastatic Thyroid Papillary CarcinomaMetastatic Thyroid Follicular CarcinomaMetastatic Thyroid Cancer
Grupo Espanol de Tumores Neuroendocrinos 79
Testing effectiveness (Phase 2)Study completedNCT00104871
What this trial is testing

Bortezomib in Treating Patients With Metastatic Thyroid Cancer That Did Not Respond to Radioactive Iodine Therapy

Who this might be right for
Insular Thyroid CancerRecurrent Thyroid CancerStage II Follicular Thyroid Cancer+3 more
National Cancer Institute (NCI) 24
Testing effectiveness (Phase 2)Study completedNCT01164176
What this trial is testing

Everolimus in Treating Patients With Locally Advanced or Metastatic Thyroid Cancer

Who this might be right for
Head and Neck Cancer
Yonsei University 40
Load More Results